Home Health Care News October 28, 2024
Andrew Donlan

Earlier this month, Walgreens Boots Alliance (Nasdaq: WBA) CEO Tim Wentworth laid the groundwork for a company turnaround. Part of that included a shift away from certain health care services, which the company pivoted toward in the wake of the COVID-19 pandemic.

After that, at the HLTH conference in Las Vegas, Mary Langowski – the president of Walgreens’ U.S. Healthcare segment – dove further into Walgreens’ health care strategy moving forward.

On an earnings call, Wentworth explained that the company would be “reorienting” the business. Part of that reorientation would be closing about 1,200 underperforming Walgreens stores over the next few years.

“WBA is reorienting to its legacy strength as a retail pharmacy-led company,” he said. “This reorientation allows us...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Mark Cuban's 2025 plans
Pharma At A Crossroads: Navigating Cost Pressures And Regulatory Shifts In 2025
Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers

Share This Article